Skip to main content
. 2022 Apr 16;19:6–20. doi: 10.1016/j.ijpddr.2022.04.001

Fig. 1.

Fig. 1

(A) Examples of lead compounds initially discovered as antimalarial agents that have shown anti-Toxoplasma activity. (B) Modification of the antitubercular lead compound JS-2-02 into a new series of (1-benzyl-4-triazolyl)-indole-2-carboxamides with significant anti-Toxoplasma gondii and anti-Cryptosporidium parvum activity.